Literature DB >> 27153853

Crosstalk between TGF-β signaling and miRNAs in breast cancer metastasis.

Wei Chen1, Siying Zhou2,3, Ling Mao4, Heda Zhang1,2, Dawei Sun5, Junying Zhang5, JIan Li2, Jin-Hai Tang6,7.   

Abstract

Transforming growth factor-β (TGF-β) signaling pathway is a key regulator of various cancer biologies, including cancer cell migration, invasion, angiogenesis, proliferation, as well as apoptosis, and it is one of indispensable signaling pathways during cancer metastasis. TGF-β signaling pathway can regulate and be regulated by a series of molecular and signaling pathways where microRNAs (miRNAs) seem to play important roles. miRNAs are small non-coding RNAs that can regulate expressions of their target genes. Emerging evidence suggest that miRNAs participate in various biological and pathologic processes such as cancer cells apoptosis, proliferation, invasion, migration, and metastasis by influencing multiple signaling pathways. In this article, we focus on the interaction between miRNAs and TGF-β in breast cancer (BC) metastasis through modulating invasion-metastasis-related factors, including epithelial-to-mesenchymal transition (EMT), cancer stem cells (CSCs), matrix metalloproteinase (MMP), tissue inhibitors of MMPs (TIMPs), cell adhesion molecules (CAMs), and tumor microenvironment (TME). Through a clear understanding of the complicated links between TGF-β pathway and miRNAs, it may provide a novel and safer therapeutic target to prevent BC metastasis.

Entities:  

Keywords:  Breast cancer; Metastasis; TGF-β pathway; Therapy; miRNAs

Mesh:

Substances:

Year:  2016        PMID: 27153853     DOI: 10.1007/s13277-016-5060-8

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  68 in total

Review 1.  Matters of context guide future research in TGFβ superfamily signaling.

Authors:  Rosemary J Akhurst; Richard W Padgett
Journal:  Sci Signal       Date:  2015-10-20       Impact factor: 8.192

2.  Systematic analysis of gene expression pattern in has-miR-760 overexpressed resistance of the MCF-7 human breast cancer cell to doxorubicin.

Authors:  Jianxin Lv; Ziyi Fu; Min Shi; Kai Xia; Chenbo Ji; Pengfei Xu; Mingming Lv; Bo Pan; Luxian Dai; Hui Xie
Journal:  Biomed Pharmacother       Date:  2014-11-25       Impact factor: 6.529

3.  Hepatic stellate cell is activated by microRNA-181b via PTEN/Akt pathway.

Authors:  Jianjian Zheng; Cunzao Wu; Ziqiang Xu; Peng Xia; Peihong Dong; Bicheng Chen; Fujun Yu
Journal:  Mol Cell Biochem       Date:  2014-08-23       Impact factor: 3.396

4.  MiR-200c suppresses TGF-β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer.

Authors:  Wen-Dong Bai; Xing-Ming Ye; Meng-Yao Zhang; Hua-Yu Zhu; Wen-Jin Xi; Xun Huang; Jiao Zhao; Bin Gu; Guo-Xu Zheng; An-Gang Yang; Lin-Tao Jia
Journal:  Int J Cancer       Date:  2014-03-03       Impact factor: 7.396

5.  Specific upregulation of RHOA and RAC1 in cancer-associated fibroblasts found at primary tumor and lymph node metastatic sites in breast cancer.

Authors:  Patricia Bortman Rozenchan; Fatima Solange Pasini; Rosimeire A Roela; Maria Lúcia Hirata Katayama; Fiorita Gonzáles Lopes Mundim; Helena Brentani; Eduardo C Lyra; Maria Mitzi Brentani
Journal:  Tumour Biol       Date:  2015-07-05

6.  Mesenchymal stem cells play a potential role in regulating the establishment and maintenance of epithelial-mesenchymal transition in MCF7 human breast cancer cells by paracrine and induced autocrine TGF-β.

Authors:  Qilin Xu; Liang Wang; Hongling Li; Qin Han; Jing Li; Xuebin Qu; Shan Huang; Robert Chunhua Zhao
Journal:  Int J Oncol       Date:  2012-07-03       Impact factor: 5.650

7.  Epithelial cell adhesion molecule regulates tumor initiation and tumorigenesis via activating reprogramming factors and epithelial-mesenchymal transition gene expression in colon cancer.

Authors:  Cheng-Wei Lin; Mei-Yin Liao; Wen-Wei Lin; Yi-Ping Wang; Tung-Yin Lu; Han-Chung Wu
Journal:  J Biol Chem       Date:  2012-09-18       Impact factor: 5.157

8.  MIR-99a and MIR-99b modulate TGF-β induced epithelial to mesenchymal plasticity in normal murine mammary gland cells.

Authors:  Gianluca Turcatel; Nicole Rubin; Ahmed El-Hashash; David Warburton
Journal:  PLoS One       Date:  2012-01-27       Impact factor: 3.240

9.  Infiltrated pre-adipocytes increase prostate cancer metastasis via modulation of the miR-301a/androgen receptor (AR)/TGF-β1/Smad/MMP9 signals.

Authors:  Hongjun Xie; Lei Li; Guodong Zhu; Qiang Dang; Zhenkun Ma; Dalin He; Luke Chang; Wenbing Song; Hong-Chiang Chang; John J Krolewski; Kent L Nastiuk; Shuyuan Yeh; Chawnshang Chang
Journal:  Oncotarget       Date:  2015-05-20

10.  A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells.

Authors:  Ulrike Burk; Jörg Schubert; Ulrich Wellner; Otto Schmalhofer; Elizabeth Vincan; Simone Spaderna; Thomas Brabletz
Journal:  EMBO Rep       Date:  2008-05-16       Impact factor: 8.807

View more
  14 in total

1.  MicroRNAs, a subpopulation of regulators, are involved in breast cancer progression through regulating breast cancer stem cells.

Authors:  Xuemei Fan; Wei Chen; Ziyi Fu; Lihua Zeng; Yongmei Yin; Hongyan Yuan
Journal:  Oncol Lett       Date:  2017-09-01       Impact factor: 2.967

2.  Suppression of Akt1-β-catenin pathway in advanced prostate cancer promotes TGFβ1-mediated epithelial to mesenchymal transition and metastasis.

Authors:  Fei Gao; Abdulrahman Alwhaibi; Harika Sabbineni; Arti Verma; Wael Eldahshan; Payaningal R Somanath
Journal:  Cancer Lett       Date:  2017-06-07       Impact factor: 8.679

Review 3.  The function of LncRNA-ATB in cancer.

Authors:  Amir Anbiyaiee; Mohammad Ramazii; Siamak Soltani Bajestani; Seyed Mohammadmahdi Meybodi; Mona Keivan; Seyed Esmaeil Khoshnam; Maryam Farzaneh
Journal:  Clin Transl Oncol       Date:  2022-05-21       Impact factor: 3.405

Review 4.  TRAIL, Wnt, Sonic Hedgehog, TGFβ, and miRNA Signalings Are Potential Targets for Oral Cancer Therapy.

Authors:  Ammad Ahmad Farooqi; Chih-Wen Shu; Hurng-Wern Huang; Hui-Ru Wang; Yung-Ting Chang; Sundas Fayyaz; Shyng-Shiou F Yuan; Jen-Yang Tang; Hsueh-Wei Chang
Journal:  Int J Mol Sci       Date:  2017-07-14       Impact factor: 5.923

5.  The ABC7 regimen: a new approach to metastatic breast cancer using seven common drugs to inhibit epithelial-to-mesenchymal transition and augment capecitabine efficacy.

Authors:  Richard E Kast; Nicolas Skuli; Samuel Cos; Georg Karpel-Massler; Yusuke Shiozawa; Ran Goshen; Marc-Eric Halatsch
Journal:  Breast Cancer (Dove Med Press)       Date:  2017-07-11

6.  Transforming growth factor-β1 promotes breast cancer metastasis by downregulating miR-196a-3p expression.

Authors:  Yan Chen; Shai Huang; Bo Wu; Jiankai Fang; Minsheng Zhu; Li Sun; Lifeng Zhang; Yongsheng Zhang; Maomin Sun; Lingling Guo; Shouli Wang
Journal:  Oncotarget       Date:  2017-07-25

Review 7.  MicroRNA applications for prostate, ovarian and breast cancer in the era of precision medicine.

Authors:  Bethany Smith; Priyanka Agarwal; Neil A Bhowmick
Journal:  Endocr Relat Cancer       Date:  2017-03-13       Impact factor: 5.678

8.  MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma.

Authors:  Pierre-Antoine Bissey; Mona Teng; Jacqueline H Law; Wei Shi; Jeff P Bruce; Valentin Petit; Sai W Tsao; Kenneth W Yip; Fei-Fei Liu
Journal:  BMC Cancer       Date:  2020-06-26       Impact factor: 4.430

Review 9.  Tumor-associated macrophage-derived cytokines enhance cancer stem-like characteristics through epithelial-mesenchymal transition.

Authors:  Yongxu Chen; Changjun Wang; Wei Tan
Journal:  Onco Targets Ther       Date:  2018-07-04       Impact factor: 4.147

10.  MiR-23a promotes TGF-β1-induced EMT and tumor metastasis in breast cancer cells by directly targeting CDH1 and activating Wnt/β-catenin signaling.

Authors:  Fei Ma; Wenjie Li; Chunxiao Liu; Wei Li; Haining Yu; Bo Lei; Yanlv Ren; Zhigao Li; Da Pang; Cheng Qian
Journal:  Oncotarget       Date:  2017-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.